Tirzepatide

Tirzepatide is indicated for the treatment of type 2 diabetes. This drug may serve as a new option for blood sugar management for patients who cannot improve their blood sugar control through diet and exercise.Tirzepatide has the effects of lowering blood sugar, reducing weight, and improving insulin resistance. As a recombinant fusion protein, it combines two different types of diabetes treatment drugs, namely insulin-like growth factor 1 receptor agonist (GLP-1) and insulin analogs.

Tirzepatide promotes insulin release, inhibits hepatic glucose output and reduces intestinal glucose absorption by mimicking the effects of insulin-like growth factor 1. At the same time, it also reduces insulin resistance and improves insulin effects by inhibiting pancreatic glucagon secretion.

As a new type of hypoglycemic drug, Tirzepatide is effective in type 2 diabetes and weight loss without increasing the risk of heart disease.